Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Plowman

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Preclinical antitumor activity of bizelesin in miceC A Carter, W R Waud, L H Li, et al.
Journal of Medicinal Chemistry|November 11, 1991
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analoguesJ S Driscoll, V E Marquez, J Plowman, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
Investigational New Drugs|November 1, 1989
Activity of batracylin (NSC-320846) against solid tumors of miceP Mucci-LoRusso, L Polin, M C Bissery, et al.
Cancer Research|February 1, 1994
Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivoP J O'Dwyer, J D Moyer, M Suffness, et al.
Journal of Medicinal Chemistry|December 25, 1992
2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agentsD B Capps, J Dunbar, S R Kesten, et al.
Investigational New Drugs|January 1, 1986
Activity of flavone acetic acid (NSC-347512) against solid tumors of miceT H Corbett, M C Bissery, A Wozniak, et al.
Investigational New Drugs|January 1, 1986
Didemnin B. The first marine compound entering clinical trials as an antineoplastic agentH G Chun, B Davies, D Hoth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Oncolytic activity and mechanism of action of a novel L-cysteine derivative, L-cysteine, ethyl ester, S-(N-methylcarbamate) monohydrochlorideH N Jayaram, M S Lui, J Plowman, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|April 13, 2023
Low prevalence of communication between intensive care unit medical staff and general practitioners: A single-centre retrospective studySophie A Witherspoon, Sophie A J Plowman, Paul Z Power, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Preclinical antitumor activity of bizelesin in miceC A Carter, W R Waud, L H Li, et al.
Journal of Medicinal Chemistry|November 11, 1991
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analoguesJ S Driscoll, V E Marquez, J Plowman, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
Investigational New Drugs|November 1, 1989
Activity of batracylin (NSC-320846) against solid tumors of miceP Mucci-LoRusso, L Polin, M C Bissery, et al.
Cancer Research|February 1, 1994
Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivoP J O'Dwyer, J D Moyer, M Suffness, et al.
Journal of Medicinal Chemistry|December 25, 1992
2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agentsD B Capps, J Dunbar, S R Kesten, et al.
Investigational New Drugs|January 1, 1986
Activity of flavone acetic acid (NSC-347512) against solid tumors of miceT H Corbett, M C Bissery, A Wozniak, et al.
Investigational New Drugs|January 1, 1986
Didemnin B. The first marine compound entering clinical trials as an antineoplastic agentH G Chun, B Davies, D Hoth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Oncolytic activity and mechanism of action of a novel L-cysteine derivative, L-cysteine, ethyl ester, S-(N-methylcarbamate) monohydrochlorideH N Jayaram, M S Lui, J Plowman, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|April 13, 2023
Low prevalence of communication between intensive care unit medical staff and general practitioners: A single-centre retrospective studySophie A Witherspoon, Sophie A J Plowman, Paul Z Power, et al.
Pageof 11